A Population-Based Study of Complications After Colorectal Surgery in Patients Who Have Received Bevacizumab

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Diseases of the Colon & Rectum

• Publication date

  2018-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/DCR.0000000000000966PMID 29420426
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Outcomes of Daytime Procedures Performed by Attending Surgeons after Night Work.

  2015cited by this paper
• Bevacizumab and postoperative wound complications in patients with liver metastases of colorectal cancer.

  2015cited by this paper
• Introduction of surgical safety checklists in Ontario, Canada.

  2014cited by this paper
• Chemotherapy usage patterns in a US-wide cohort of patients with metastatic colorectal cancer.

  2014cited by this paper
• A NSQIP Review of Major Morbidity and Mortality of Synchronous Liver Resection for Colorectal Metastasis Stratified by Extent of Liver Resection and Type of Colorectal Resection

  2014cited by this paper
• Perioperative Complications After Neoadjuvant Chemotherapy With and Without Bevacizumab for Colorectal Liver Metastases

  2013cited by this paper
• Perioperative chemotherapy with or without bevacizumab in patients with metastatic colorectal cancer undergoing liver resection.

  2013cited by this paper
• Primary mFOLFOX6 plus bevacizumab without resection of the primary tumor for patients presenting with surgically unresectable metastatic colon cancer and an intact asymptomatic colon cancer: definitive analysis of NSABP trial C-10.

  2012cited by this paper
• Gastrointestinal perforation associated with bevacizumab use in metastatic colorectal cancer: results from a large treatment observational cohort study.

  2012cited by this paper
• Neoadjuvant bevacizumab persistently inactivates VEGF at the time of surgery despite preoperative cessation

  2012cited by this paper
• Review: incidence and clinical significance of Bevacizumab-related non-surgical and surgical serious adverse events in metastatic colorectal cancer.

  2011cited by this paper
• Impact of bevacizumab on functional recovery and histology of the liver after resection of colorectal metastases

  2011cited by this paper
• Vascular endothelial growth factor targeted therapy in the perioperative setting: implications for patient care.

  2010cited by this paper
• Trends, major medical complications, and charges associated with surgery for lumbar spinal stenosis in older adults.

  2010cited by this paper
• The role of vascular endothelial growth factor in wound healing.

  2009cited by this paper
• Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study.

  2009cited by this paper
• Clinical outcomes associated with bevacizumab-containing treatment of metastatic colorectal cancer: the BRiTE observational cohort study.

  2009cited by this paper
• Preoperative bevacizumab does not significantly increase postoperative complication rates in patients undergoing hepatic surgery for colorectal cancer liver metastases.

  2008cited by this paper
• Bevacizumab Improves the Overall and Progression-Free Survival of Patients with Metastatic Colorectal Cancer Treated with 5-Fluorouracil-Based Regimens Irrespective of Baseline Risk

  2008cited by this paper
• Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200.

  2007cited by this paper
• Lack of Evidence for Increased Operative Morbidity After Hepatectomy with Perioperative Use of Bevacizumab: A Matched Case-Control Study

  2007cited by this paper
• Angiogenesis inhibition with bevacizumab and the surgical management of colorectal cancer

  2006cited by this paper
• Surgical wound healing complications in metastatic colorectal cancer patients treated with bevacizumab

  2005cited by this paper
• Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.

  2004cited by this paper
• Phase I safety and pharmacokinetic study of recombinant human anti-vascular endothelial growth factor in patients with advanced cancer.

  2001cited by this paper
• An application of capture-recapture methods to the estimation of completeness of cancer registration.

  1988cited by this paper

• Targeted Therapies, Biologics, and Immunotherapy in the Neoadjuvant and Adjuvant Settings: Perioperative Risks.

  2023cites this paper
• The Association of Oxaliplatin-Containing Adjuvant Chemotherapy Duration with Overall and Cancer-Specific Mortality in Individuals with Stage III Colon Cancer: A Population-Based Retrospective Cohort Study

  2023cites this paper
• Mortality of patients with metastatic colorectal cancer who received elective or emergent operation after exposure to bevacizumab: A nationwide database study.

  2022cites this paper
• Emergent Bowel Surgery Following Treatment with Bevacizumab

  2021cites this paper
• The bevacizumab plus oxaliplatin-based chemotherapy regimen is more suitable for metastatic colorectal cancer patients with a history of schistosomiasis: a clinical retrospective analysis.

  2021cites this paper
• Morbidity and mortality following major large bowel resection for colorectal cancer detected by a population-based screening program

  2020cites this paper
• Does the presence of an intact primary increase the risk of nonelective colorectal surgery in patients treated with bevacizumab?

  2020cites this paper
• Morbidity and mortality after major large bowel resection of non-malignant polyp among participants in a population-based screening program

  2020cites this paper
• Colon Cancer

  2020cites this paper
• Association Between Preoperative Patient-Reported Symptoms and Postoperative Outcomes in Rectal Cancer Patients: A Retrospective Cohort Study.

  2020cites this paper
• Gene therapy knockdown of VEGFR2 in retinal endothelial cells to treat retinopathy

  2018cites this paper
• Investigating Associations Between Preoperative Patient-Reported Symptom Burden and Postoperative Outcomes Following Major Cancer Surgery: A Retrospective Cohort Study

  2018cites this paper